Form 8-K - Current report:
SEC Accession No. 0001628280-25-021304
Filing Date
2025-05-01
Accepted
2025-05-01 06:25:29
Documents
48
Period of Report
2025-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K xfor-20250501.htm   iXBRL 8-K 33317
2 EX-99.1 a991earningsreleasedatedma.htm EX-99.1 97302
3 EX-99.2 ex_992xx4updatedinvestor.htm EX-99.2 37613
7 ex_992xx4updatedinvestor001.jpg GRAPHIC 86428
8 ex_992xx4updatedinvestor002.jpg GRAPHIC 292598
9 ex_992xx4updatedinvestor003.jpg GRAPHIC 138334
10 ex_992xx4updatedinvestor004.jpg GRAPHIC 124384
11 ex_992xx4updatedinvestor005.jpg GRAPHIC 128174
12 ex_992xx4updatedinvestor006.jpg GRAPHIC 83249
13 ex_992xx4updatedinvestor007.jpg GRAPHIC 54340
14 ex_992xx4updatedinvestor008.jpg GRAPHIC 128618
15 ex_992xx4updatedinvestor009.jpg GRAPHIC 92729
16 ex_992xx4updatedinvestor010.jpg GRAPHIC 95564
17 ex_992xx4updatedinvestor011.jpg GRAPHIC 91275
18 ex_992xx4updatedinvestor012.jpg GRAPHIC 103669
19 ex_992xx4updatedinvestor013.jpg GRAPHIC 105741
20 ex_992xx4updatedinvestor014.jpg GRAPHIC 67105
21 ex_992xx4updatedinvestor015.jpg GRAPHIC 137721
22 ex_992xx4updatedinvestor016.jpg GRAPHIC 137726
23 ex_992xx4updatedinvestor017.jpg GRAPHIC 111607
24 ex_992xx4updatedinvestor018.jpg GRAPHIC 102531
25 ex_992xx4updatedinvestor019.jpg GRAPHIC 98652
26 ex_992xx4updatedinvestor020.jpg GRAPHIC 130888
27 ex_992xx4updatedinvestor021.jpg GRAPHIC 107494
28 ex_992xx4updatedinvestor022.jpg GRAPHIC 127144
29 ex_992xx4updatedinvestor023.jpg GRAPHIC 95759
30 ex_992xx4updatedinvestor024.jpg GRAPHIC 120420
31 ex_992xx4updatedinvestor025.jpg GRAPHIC 113341
32 ex_992xx4updatedinvestor026.jpg GRAPHIC 96877
33 ex_992xx4updatedinvestor027.jpg GRAPHIC 135353
34 ex_992xx4updatedinvestor028.jpg GRAPHIC 28949
35 ex_992xx4updatedinvestor029.jpg GRAPHIC 127410
36 ex_992xx4updatedinvestor030.jpg GRAPHIC 115952
37 ex_992xx4updatedinvestor031.jpg GRAPHIC 103698
38 ex_992xx4updatedinvestor032.jpg GRAPHIC 80931
39 x4logoa.jpg GRAPHIC 4345
  Complete submission text file 0001628280-25-021304.txt   5247339

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20250501.xsd EX-101.SCH 1785
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20250501_lab.xml EX-101.LAB 23449
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20250501_pre.xml EX-101.PRE 13583
50 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20250501_htm.xml XML 2824
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 25899188
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)